Form 4: Elanco Executive Acquires Deferred Stock Units

Elanco Animal Health Inc. Executive Vice President Rajeev A. Modi acquired 61.5901 deferred stock units, increasing his beneficial ownership to 9,072.9178 units.

Summary

• Rajeev A. Modi, Executive Vice President U.S. Pet Health and Global Digital Transformation at Elanco Animal Health Inc., acquired 61.5901 Deferred Stock Units (DSUs).
• The transaction date for the acquisition of these DSUs was March 20, 2026.
• Each DSU represents the right to receive one share of Elanco common stock or its cash equivalent.
• The DSUs are scheduled to settle in cash or shares following termination of employment or during a specified future year, in accordance with the Executive Deferral and Stock Match Plan.
• Following this reported transaction, Mr. Modi beneficially owns a total of 9,072.9178 Deferred Stock Units.
• The underlying common stock price associated with these deferred stock units was $23.98.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, reflecting an executive's continued accumulation of company equity through a compensation plan, which aligns their interests with long-term company performance.

Positives

• An executive is increasing their beneficial ownership in the company through deferred stock units, which aligns their interests with long-term shareholder value.

Future Outlook

This filing does not contain forward-looking statements or guidance regarding the company's future performance, focusing solely on an insider's equity transaction.

Industry Context

StockSavvy.ai notes that insider acquisitions of deferred stock units are a common component of executive compensation packages in the animal health industry, aligning executive interests with long-term shareholder value. This practice is standard across publicly traded companies to incentivize management performance.

Comparison to Industry Standards

• Executive compensation often includes equity-based awards like Deferred Stock Units (DSUs) to incentivize long-term performance, a practice common among peers such as Zoetis Inc. (ZTS) and IDEXX Laboratories, Inc. (IDXX).
• The specific number of units granted and their value are typically benchmarked against similar executive roles and company performance within the animal health sector to ensure competitive and effective compensation.

Stakeholder Impact

• Shareholders: The acquisition of deferred stock units by an executive enhances the alignment of management's financial interests with those of the shareholders, potentially fostering a greater focus on long-term value creation.
• Employees: This transaction reflects standard executive compensation practices, which can influence overall compensation strategies within the company.

Next Steps

• The deferred stock units will settle in cash or shares following termination of employment or during a specified future year, as per the Executive Deferral and Stock Match Plan.

Key Dates

Recommendation

This Form 4 reports a routine acquisition of deferred stock units as part of an executive's compensation plan, rather than an open-market purchase. While it indicates continued insider ownership and alignment, it does not provide new fundamental information to warrant a change in investment recommendation.

Keywords

Elanco, ELAN, Rajeev Modi, Deferred Stock Units, DSU, Insider Transaction, Executive Compensation, Stock Ownership